Immunohistochemical detection of PPARgamma receptors in the human pituitary adenomas: correlation with PCNA
- PMID: 16201313
Immunohistochemical detection of PPARgamma receptors in the human pituitary adenomas: correlation with PCNA
Abstract
The occurrence of peroxisome proliferator-activated receptors gamma (PPARgamma) was investigated in 51 human pituitary adenomas and in 6 non-tumoral human pituitary tissue samples. Moreover, the correlation between PPARgamma and the proliferating cells nuclear antigen (PCNA)--immunocytochemical proliferation marker was evaluated. The receptors and PCNA were detected by immunohistochemical methods using the polyclonal anti-PPARgamma and the monoclonal anti-PCNA antibodies, respectively. PPARgamma were found in all examined tissues. The mean percentage of cells with positive nuclear reaction was 3-fold higher in pituitary adenomas in comparison with non-tumoral pituitary tissues. The strongest expression of PPARgamma was observed in somatotropinomas. Besides the nuclear reaction, which is typical for PPARgamma, positive immunostaining was also observed in the cytoplasm. It was clearly stronger in pituitary adenomas than in non-tumoral pituitary tissues. A slight, statistically insignificant tendency towards negative correlation between PPARgamma and PCNA was found in somatotropinomas, prolactinomas, corticotropinomas and gonadotropinomas. On the other hand, in null cell adenomas and "silent" corticotropinomas, a strong positve correlation between the expression of PPARgamma and PCNA was observed. The strong expression of PPARgamma in human pituitary adenomas and its possible involvement in control of cell proliferation in these tumors give a good reason for the attempts of their treatment with PPARgamma ligands.
Similar articles
-
Peroxisome proliferator-activated receptor gamma in the human pituitary gland: expression and splicing pattern in adenomas versus normal pituitary.J Neuroendocrinol. 2007 Jul;19(7):552-9. doi: 10.1111/j.1365-2826.2007.01562.x. J Neuroendocrinol. 2007. PMID: 17561883
-
Immunohistochemical detection of dopamine D2 receptors in human pituitary adenomas.Folia Histochem Cytobiol. 2010 Sep 30;48(3):394-7. doi: 10.2478/v10042-010-0031-1. Folia Histochem Cytobiol. 2010. PMID: 21071344
-
Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: relationship to the endocrine phenotype of adenoma.Folia Histochem Cytobiol. 2006;44(1):37-41. Folia Histochem Cytobiol. 2006. PMID: 16584090
-
Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas.Int J Mol Sci. 2017 Nov 1;18(11):2299. doi: 10.3390/ijms18112299. Int J Mol Sci. 2017. PMID: 29104246 Free PMC article. Review.
-
[The role of peroxisome proliferators-activated receptors (PPARgamma) in neoplasms of endocrine glands].Endokrynol Pol. 2008 Mar-Apr;59(2):156-66. Endokrynol Pol. 2008. PMID: 18465691 Review. Polish.
Cited by
-
Effect of rosiglitazone on serum IGF-I concentrations in uncontrolled acromegalic patients under conventional medical therapy: results from a pilot phase 2 study.J Endocrinol Invest. 2011 Feb;34(2):e43-51. doi: 10.1007/BF03347060. Epub 2010 Jul 29. J Endocrinol Invest. 2011. PMID: 20671417 Clinical Trial.
-
Transcriptome Analyses of Female Somatotropes and Lactotropes Reveal Novel Regulators of Cell Identity in the Pituitary.Endocrinology. 2018 Dec 1;159(12):3965-3980. doi: 10.1210/en.2018-00587. Endocrinology. 2018. PMID: 30247555 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous